Drug Kinetics – News and Features

MIT engineers have designed an implantable reservoir that can remain under the skin and be triggered to release glucagon when blood sugar levels get too low.

Researchers have developed a new nanomaterial that is capable of simultaneously performing functions to aid in cancer diagnosis, treatment and immune response induction.

Could what's on your plate change your chemo outcome? Dietary microRNAs from food like eggs could affect cancer drug response – here’s what in silico analysis reveals about this promising discovery.

A recent study reveals that slowing down the intracellular transport of RNA-based drugs can significantly enhance their effectiveness. These therapeutics are currently used to treat rare genetic diseases.

To reveal the science behind the protein–nanoparticle interaction and its implications for human health, a team of researchers conducted a series of spectroscopy-based experiments.

This article explores how generative chemistry accelerates drug design, identifies novel compounds and complements traditional computational tools.

Scientists have developed a new type of nanoparticle made from a medical polymer and blood protein that can carry larger amounts of disease-fighting drugs and remain stable for longer than current alternative nanoparticle systems.

Solvent polarity plays a critical role in determining how effectively drugs can be loaded into metal-organic framework (MOF) carriers, a new study has found. This previously overlooked factor could help to improve drug delivery.

The STARLYNG-1 trial tested a weekly oral version of risperidone for schizophrenia, showing it maintains therapeutic drug levels and reduces side effects. The study found that the weekly pill may help improve medication adherence.

Researchers have used electrospinning to produce polymer mats containing the antibacterial drug metronidazole. These mats could be used as active wound dressings, as their structure lets them release drugs in a controlled manner.